Valuation: Boston Scientific Corporation

Capitalization 11TCr 9.35TCr 8.53TCr 8.13TCr 15TCr 10,06300Cr 16TCr 99TCr 39TCr 4,84400Cr 42TCr 41TCr 17,01000Cr P/E ratio 2025
49.1x
P/E ratio 2026 * 30.5x
Enterprise value 12TCr 10TCr 9.21TCr 8.78TCr 16TCr 10,86400Cr 17TCr 1,07000Cr 43TCr 5,23000Cr 45TCr 44TCr 18,36500Cr EV / Sales 2025
7.04x
EV / Sales 2026 * 5.23x
Free-Float
84.69%
Yield 2025 *
-
Yield 2026 * -
1 day+0.82%
1 week+0.82%
Current month-20.10%
1 month-15.15%
3 months-27.23%
6 months-27.57%
Current year-21.63%
1 week 72.69
Extreme 72.69
76.37
1 month 72.69
Extreme 72.69
94.75
Current year 72.69
Extreme 72.69
100.9
1 year 72.69
Extreme 72.69
109.5
3 years 45.92
Extreme 45.925
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 16.82
Extreme 16.82
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Operating Officer 58 01/05/2022
Director TitleAgeSince
Director/Board Member 61 01/04/2009
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Change 5d. change 1-year change 3-years change Capi.($)
+0.82%+0.82%-29.57%+60.78% 11TCr
-0.98%-7.67%-5.08%-9.46% 19TCr
+1.51%-1.42%-18.42%+102.30% 17TCr
-1.10%-1.88%+3.04%-16.88% 15TCr
+0.48%+0.32%-28.57%-18.53% 5.41TCr
-0.75%-1.21%-0.42%-1.82% 4.4TCr
+2.78%-8.48%+8.40%+18.06% 3.68TCr
+2.15%+1.59%-12.87%+13.30% 3.66TCr
+0.74%-1.33%-6.58%-15.15% 3.56TCr
-1.19%-1.80%-29.04%-42.42% 3.25TCr
Average +0.44%-2.68%-11.91%+9.02% 8.63TCr
Weighted average by Cap. +0.19%-2.88%-11.44%+21.09%

Financials

2025 2026 *
Net sales 2.01TCr 1.69TCr 1.54TCr 1.47TCr 2.74TCr 1,82300Cr 2.84TCr 18TCr 7.13TCr 88TCr 7.53TCr 7.37TCr 3,08100Cr 2.23TCr 1.88TCr 1.71TCr 1.63TCr 3.04TCr 2,02300Cr 3.15TCr 20TCr 7.92TCr 97TCr 8.36TCr 8.19TCr 3,42100Cr
Net income 301.14Cr 254.04Cr 231.74Cr 220.92Cr 410.44Cr 27TCr 425.82Cr 2.69TCr 1.07TCr 13TCr 1.13TCr 1.11TCr 46TCr 361.9Cr 305.3Cr 278.49Cr 265.5Cr 493.25Cr 33TCr 511.73Cr 3.24TCr 1.29TCr 16TCr 1.36TCr 1.33TCr 56TCr
Net Debt 882.88Cr 744.8Cr 679.4Cr 647.7Cr 1.2TCr 80TCr 1.25TCr 7.89TCr 3.14TCr 39TCr 3.31TCr 3.24TCr 1,35500Cr 569.72Cr 480.62Cr 438.42Cr 417.96Cr 776.5Cr 52TCr 805.58Cr 5.09TCr 2.02TCr 25TCr 2.14TCr 2.09TCr 87TCr
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (64.2%): products used in cardiology surgeries (24.6% of net sales), peripheral surgeries (22.4%), cardiac rhythm management (21.2%), electrophysiology tests (17.7%) and other (14.1%); - endodontic surgery (29.2%): equipment used in endoscopy (55% of net sales), and urology (45%) ; - neuromodulation (6.6%). Net sales are distributed geographically as follows: the United States (61%), Europe/Middle East/Africa (19.3%), Asia/Pacific (16%) and other (3.7%).
Employees
53,000
Date Price Change Volume
13/26/13 74.73 $ +0.82% 1,34,52,417
12/26/12 74.12 $ +0.88% 1,68,71,948
11/26/11 73.47 $ -1.05% 2,01,02,918
10/26/10 74.25 $ +0.18% 2,10,80,942
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
74.73USD
Average target price
104.78USD
Spread / Average Target
+40.21%

Quarterly revenue - Rate of surprise